Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Huntington Disease | 13 | 2022 | 141 | 2.280 |
Why?
|
| Nerve Tissue Proteins | 13 | 2024 | 1117 | 1.160 |
Why?
|
| Huntingtin Protein | 13 | 2022 | 61 | 1.100 |
Why?
|
| Drosophila melanogaster | 12 | 2021 | 738 | 0.870 |
Why?
|
| Drosophila | 18 | 2023 | 766 | 0.730 |
Why?
|
| tau Proteins | 5 | 2024 | 189 | 0.660 |
Why?
|
| Nuclear Proteins | 7 | 2016 | 1267 | 0.640 |
Why?
|
| Spinocerebellar Ataxias | 6 | 2022 | 256 | 0.620 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 96 | 0.580 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2017 | 73 | 0.580 |
Why?
|
| Drosophila Proteins | 6 | 2021 | 707 | 0.570 |
Why?
|
| Tauopathies | 3 | 2024 | 56 | 0.540 |
Why?
|
| Alzheimer Disease | 7 | 2023 | 766 | 0.540 |
Why?
|
| Disease Models, Animal | 20 | 2024 | 4268 | 0.490 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 571 | 0.480 |
Why?
|
| alpha-Synuclein | 3 | 2023 | 114 | 0.470 |
Why?
|
| Neurons | 9 | 2023 | 1927 | 0.470 |
Why?
|
| Ataxin-1 | 7 | 2022 | 167 | 0.450 |
Why?
|
| Neurodegenerative Diseases | 2 | 2022 | 253 | 0.400 |
Why?
|
| Animals | 34 | 2024 | 33740 | 0.380 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 3 | 2015 | 42 | 0.360 |
Why?
|
| Brain | 8 | 2023 | 2947 | 0.350 |
Why?
|
| Myotonic Dystrophy | 2 | 2013 | 145 | 0.330 |
Why?
|
| Neuropeptides | 1 | 2009 | 114 | 0.320 |
Why?
|
| RNA Interference | 5 | 2019 | 496 | 0.320 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2021 | 93 | 0.300 |
Why?
|
| Peptides | 6 | 2022 | 798 | 0.300 |
Why?
|
| Cerebellum | 2 | 2022 | 415 | 0.300 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 2 | 2021 | 37 | 0.290 |
Why?
|
| Parkinson Disease | 3 | 2023 | 669 | 0.280 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 573 | 0.280 |
Why?
|
| Corpus Striatum | 6 | 2022 | 89 | 0.270 |
Why?
|
| Transcription Factors | 4 | 2021 | 2577 | 0.270 |
Why?
|
| Autophagy | 2 | 2021 | 390 | 0.270 |
Why?
|
| Friedreich Ataxia | 2 | 2016 | 48 | 0.260 |
Why?
|
| Proteolysis | 2 | 2017 | 165 | 0.260 |
Why?
|
| Animals, Genetically Modified | 7 | 2023 | 316 | 0.250 |
Why?
|
| Ubiquitin | 1 | 2006 | 141 | 0.250 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2006 | 125 | 0.250 |
Why?
|
| Mice | 18 | 2024 | 17497 | 0.230 |
Why?
|
| Cells, Cultured | 6 | 2021 | 3050 | 0.230 |
Why?
|
| Gene Regulatory Networks | 3 | 2021 | 353 | 0.230 |
Why?
|
| Cell Line | 6 | 2021 | 2779 | 0.230 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 353 | 0.220 |
Why?
|
| Fibroblasts | 2 | 2018 | 878 | 0.220 |
Why?
|
| Neuroglia | 2 | 2023 | 193 | 0.210 |
Why?
|
| ras Proteins | 2 | 2013 | 136 | 0.200 |
Why?
|
| Electrical Synapses | 1 | 2021 | 8 | 0.190 |
Why?
|
| Ataxins | 4 | 2013 | 114 | 0.190 |
Why?
|
| Apolipoprotein E2 | 1 | 2020 | 13 | 0.180 |
Why?
|
| Mutation | 9 | 2024 | 5778 | 0.180 |
Why?
|
| Apolipoprotein E4 | 1 | 2020 | 43 | 0.180 |
Why?
|
| Proteomics | 2 | 2016 | 480 | 0.180 |
Why?
|
| Behavior, Animal | 3 | 2021 | 477 | 0.180 |
Why?
|
| DNA-Binding Proteins | 2 | 2021 | 2048 | 0.180 |
Why?
|
| Brain Stem | 1 | 2021 | 115 | 0.180 |
Why?
|
| Mice, Transgenic | 7 | 2024 | 2391 | 0.170 |
Why?
|
| Cell Nucleus | 2 | 2016 | 674 | 0.170 |
Why?
|
| Protein Kinase C beta | 1 | 2019 | 21 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 350 | 0.160 |
Why?
|
| Humans | 32 | 2024 | 123190 | 0.160 |
Why?
|
| Transcriptome | 3 | 2023 | 909 | 0.160 |
Why?
|
| Sex Factors | 1 | 2023 | 1257 | 0.160 |
Why?
|
| Synaptic Transmission | 1 | 2021 | 348 | 0.160 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2018 | 191 | 0.160 |
Why?
|
| Protein Kinases | 2 | 2019 | 330 | 0.160 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2019 | 121 | 0.150 |
Why?
|
| Amyloidosis | 1 | 2019 | 66 | 0.150 |
Why?
|
| Models, Biological | 2 | 2017 | 1442 | 0.150 |
Why?
|
| DNA Damage | 1 | 2021 | 507 | 0.150 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2017 | 26 | 0.150 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 206 | 0.150 |
Why?
|
| Muscles | 2 | 2009 | 288 | 0.140 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2016 | 16 | 0.140 |
Why?
|
| Membrane Proteins | 1 | 2024 | 1528 | 0.130 |
Why?
|
| Antioxidants | 2 | 2016 | 337 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 376 | 0.130 |
Why?
|
| Oxidative Stress | 3 | 2016 | 796 | 0.130 |
Why?
|
| Dynamin I | 1 | 2015 | 3 | 0.130 |
Why?
|
| Genome | 1 | 2018 | 472 | 0.130 |
Why?
|
| Repressor Proteins | 2 | 2016 | 811 | 0.120 |
Why?
|
| Mutant Proteins | 1 | 2014 | 112 | 0.120 |
Why?
|
| Introns | 1 | 2015 | 302 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 244 | 0.110 |
Why?
|
| Phosphorylation | 4 | 2021 | 1611 | 0.110 |
Why?
|
| Iron | 1 | 2016 | 261 | 0.110 |
Why?
|
| Sirolimus | 1 | 2015 | 220 | 0.110 |
Why?
|
| Genomics | 2 | 2023 | 1477 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 281 | 0.100 |
Why?
|
| Phenotype | 2 | 2020 | 4225 | 0.100 |
Why?
|
| Diacylglycerol Kinase | 1 | 2012 | 15 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 207 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1684 | 0.090 |
Why?
|
| HEK293 Cells | 3 | 2021 | 742 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2016 | 1021 | 0.090 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 3288 | 0.090 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 65 | 0.090 |
Why?
|
| Ganglia | 1 | 2009 | 20 | 0.090 |
Why?
|
| Transgenes | 2 | 2013 | 334 | 0.090 |
Why?
|
| Signal Transduction | 4 | 2021 | 4508 | 0.090 |
Why?
|
| Neurosecretory Systems | 1 | 2009 | 23 | 0.080 |
Why?
|
| Neurites | 1 | 2009 | 44 | 0.080 |
Why?
|
| Mushroom Bodies | 1 | 2009 | 46 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 353 | 0.080 |
Why?
|
| Larva | 1 | 2009 | 247 | 0.080 |
Why?
|
| Neurotransmitter Agents | 1 | 2009 | 139 | 0.080 |
Why?
|
| Neural Pathways | 1 | 2009 | 264 | 0.070 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2007 | 11 | 0.070 |
Why?
|
| Protein Stability | 2 | 2021 | 167 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 2021 | 348 | 0.070 |
Why?
|
| Female | 9 | 2023 | 65427 | 0.070 |
Why?
|
| Male | 8 | 2023 | 60020 | 0.070 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2006 | 13 | 0.070 |
Why?
|
| CELF1 Protein | 1 | 2006 | 48 | 0.070 |
Why?
|
| Aging | 2 | 2023 | 1172 | 0.070 |
Why?
|
| Blotting, Northern | 1 | 2006 | 258 | 0.070 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2006 | 58 | 0.070 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2006 | 153 | 0.060 |
Why?
|
| Iron-Binding Proteins | 2 | 2016 | 32 | 0.060 |
Why?
|
| Molecular Chaperones | 1 | 2006 | 167 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 473 | 0.060 |
Why?
|
| Protein Folding | 1 | 2006 | 218 | 0.060 |
Why?
|
| Eye | 1 | 2006 | 226 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2024 | 2599 | 0.060 |
Why?
|
| Protein Conformation | 1 | 2006 | 836 | 0.060 |
Why?
|
| Paralysis | 1 | 2024 | 35 | 0.060 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2023 | 7 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 665 | 0.050 |
Why?
|
| Glucosylceramidase | 1 | 2023 | 27 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 286 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2021 | 2698 | 0.050 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2023 | 17 | 0.050 |
Why?
|
| Mice, Neurologic Mutants | 2 | 2014 | 74 | 0.050 |
Why?
|
| Transglutaminases | 1 | 2022 | 24 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2024 | 3717 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 1294 | 0.050 |
Why?
|
| Motor Activity | 2 | 2015 | 520 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 4352 | 0.050 |
Why?
|
| Genome-Wide Association Study | 2 | 2023 | 1650 | 0.050 |
Why?
|
| Lysosomes | 1 | 2023 | 232 | 0.050 |
Why?
|
| Trinucleotide Repeats | 1 | 2021 | 109 | 0.050 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2021 | 83 | 0.050 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2021 | 80 | 0.050 |
Why?
|
| Locomotion | 1 | 2021 | 69 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2021 | 657 | 0.040 |
Why?
|
| Mitochondria | 2 | 2016 | 682 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2006 | 2820 | 0.040 |
Why?
|
| Gene Expression | 2 | 2015 | 1569 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2019 | 92 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 63 | 0.040 |
Why?
|
| Homozygote | 1 | 2020 | 533 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 554 | 0.040 |
Why?
|
| Heterozygote | 1 | 2020 | 672 | 0.040 |
Why?
|
| Species Specificity | 1 | 2018 | 549 | 0.040 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2016 | 28 | 0.030 |
Why?
|
| Aluminum | 1 | 2016 | 11 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2021 | 901 | 0.030 |
Why?
|
| Manganese | 1 | 2016 | 47 | 0.030 |
Why?
|
| Copper | 1 | 2016 | 62 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 312 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 462 | 0.030 |
Why?
|
| Zinc | 1 | 2016 | 128 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2015 | 35 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2016 | 122 | 0.030 |
Why?
|
| Aconitate Hydratase | 1 | 2015 | 11 | 0.030 |
Why?
|
| Aldehydes | 1 | 2015 | 28 | 0.030 |
Why?
|
| Thioxanthenes | 1 | 2014 | 2 | 0.030 |
Why?
|
| Postmortem Changes | 1 | 2014 | 11 | 0.030 |
Why?
|
| Fear | 1 | 2016 | 202 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2014 | 39 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 991 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1783 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2019 | 673 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 140 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 121 | 0.030 |
Why?
|
| Morpholines | 1 | 2014 | 56 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2015 | 212 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 3260 | 0.030 |
Why?
|
| Longevity | 1 | 2015 | 138 | 0.030 |
Why?
|
| Glutathione | 1 | 2015 | 193 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 188 | 0.030 |
Why?
|
| NEDD8 Protein | 1 | 2013 | 11 | 0.030 |
Why?
|
| Cullin Proteins | 1 | 2013 | 14 | 0.030 |
Why?
|
| Ubiquitins | 1 | 2013 | 42 | 0.030 |
Why?
|
| Myoblasts | 1 | 2013 | 30 | 0.030 |
Why?
|
| Farnesyltranstransferase | 1 | 2012 | 9 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2014 | 441 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 434 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2019 | 997 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 1102 | 0.030 |
Why?
|
| Caspase 7 | 1 | 2012 | 6 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2023 | 3098 | 0.030 |
Why?
|
| Homeostasis | 1 | 2016 | 681 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2012 | 131 | 0.020 |
Why?
|
| Triazoles | 1 | 2012 | 138 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 185 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2851 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 319 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 645 | 0.020 |
Why?
|
| Histones | 1 | 2014 | 528 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 452 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 697 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 352 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 170 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 522 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2012 | 375 | 0.020 |
Why?
|
| Caspases | 1 | 2010 | 159 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 242 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 256 | 0.020 |
Why?
|
| Adult | 2 | 2023 | 29035 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 1068 | 0.020 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2007 | 15 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3871 | 0.020 |
Why?
|
| Genes, Insect | 1 | 2007 | 123 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2007 | 247 | 0.020 |
Why?
|
| Genome, Human | 1 | 2012 | 1267 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 491 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 2533 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 1390 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 7124 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 19068 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 25976 | 0.010 |
Why?
|